• Integrating closed and automated systems to enhance cell processing efficiency and reduce contamination risks
• Streamlining viral vector production for scalable and cost-effective gene therapies
• Applying process intensification to improve yield, consistency, and turnaround time
• Leveraging single-use technologies for flexibility and rapid clinical-to-commercial transition
• Case study: Overcoming scalability challenges in autologous and allogeneic manufacturing environments